Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamal L Hill

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|August 29, 2012
The combination of tamoxifen and the rexinoid LG100268 prevents ER-positive and ER-negative mammary tumors in p53-null mammary gland miceAbhijit Mazumdar, Daniel Medina, Francis S Kittrell, et al.
The Journal of Clinical Investigation|June 16, 2015
Death-associated protein kinase 1 promotes growth of p53-mutant cancersJing Zhao, Dekuang Zhao, Graham M Poage, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 18, 2022
Targeting the mTOR Pathway for the Prevention of ER-Negative Breast CancerAbhijit Mazumdar, William M Tahaney, Jamal L Hill, et al.
Journal of the National Cancer Institute|January 15, 2009
Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in miceTracy E Strecker, Qiang Shen, Yun Zhang, et al.
Developmental Biology|May 9, 2006
The AP-1 transcription factor regulates postnatal mammary gland developmentQiang Shen, Yun Zhang, Ivan P Uray, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 24, 2025
Targeting the RXR Pathway for the Prevention of Triple Negative Breast CancerCassandra L Moyer, Jamal L Hill, Darian Coleman, et al.
Science Translational Medicine|January 24, 2020
PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinomaXiaochao Tan, Priyam Banerjee, Edward A Pham, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Prevention Research (Philadelphia, Pa.)|August 29, 2012
The combination of tamoxifen and the rexinoid LG100268 prevents ER-positive and ER-negative mammary tumors in p53-null mammary gland miceAbhijit Mazumdar, Daniel Medina, Francis S Kittrell, et al.
The Journal of Clinical Investigation|June 16, 2015
Death-associated protein kinase 1 promotes growth of p53-mutant cancersJing Zhao, Dekuang Zhao, Graham M Poage, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 18, 2022
Targeting the mTOR Pathway for the Prevention of ER-Negative Breast CancerAbhijit Mazumdar, William M Tahaney, Jamal L Hill, et al.
Journal of the National Cancer Institute|January 15, 2009
Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in miceTracy E Strecker, Qiang Shen, Yun Zhang, et al.
Developmental Biology|May 9, 2006
The AP-1 transcription factor regulates postnatal mammary gland developmentQiang Shen, Yun Zhang, Ivan P Uray, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 24, 2025
Targeting the RXR Pathway for the Prevention of Triple Negative Breast CancerCassandra L Moyer, Jamal L Hill, Darian Coleman, et al.
Science Translational Medicine|January 24, 2020
PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinomaXiaochao Tan, Priyam Banerjee, Edward A Pham, et al.
Pageof 1